Predictive Value of C-Peptide Measures for Clinical Outcomes of β-Cell Replacement Therapy in Type 1 Diabetes: Report From the Collaborative Islet Transplant Registry (CITR)
ContributorsBaidal, David A![orcid](assets/images/orcid.png)
; Ballou, Cassandra M; Rickels, Michael R![orcid](assets/images/orcid.png)
; Berney, Thierry; Pattou, Francois; Payne, Elizabeth H; Barton, Franca B; Alejandro, Rodolfo![orcid](assets/images/orcid.png)
; CITR Investigators
![orcid](assets/images/orcid.png)
![orcid](assets/images/orcid.png)
![orcid](assets/images/orcid.png)
Published inDiabetes care, vol. 46, no. 4, p. 697-703
Publication date2023-01-17
First online date2023-01-17
Abstract
Keywords
- Blood Glucose
- C-Peptide
- Diabetes Mellitus, Type 1 / drug therapy
- Diabetes Mellitus, Type 1 / surgery
- Glucose / therapeutic use
- Glycated Hemoglobin
- Humans
- Hypoglycemic Agents / therapeutic use
- Insulin / therapeutic use
- Insulin, Regular, Human / therapeutic use
- Islets of Langerhans Transplantation
Affiliation
Citation (ISO format)
BAIDAL, David A et al. Predictive Value of C-Peptide Measures for Clinical Outcomes of β-Cell Replacement Therapy in Type 1 Diabetes: Report From the Collaborative Islet Transplant Registry (CITR). In: Diabetes care, 2023, vol. 46, n° 4, p. 697–703. doi: 10.2337/dc22-1155
Main files (1)
Article (Published version)
![accessLevelPublic](assets/images/access-level-free.png)
Secondary files (1)
Identifiers
- PID : unige:172021
- DOI : 10.2337/dc22-1155
- PMID : 36657975
ISSN of the journal0149-5992